Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer’s disease

Biological staging of individuals with Alzheimer’s disease (AD) may improve diagnostic and prognostic work-up of dementia in clinical practice and the design of clinical trials. Here, we created a staging model using the Subtype and Stage Inference (SuStaIn) algorithm by evaluating cerebrospinal flu...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvadó, Gemma, Horie, Kanta, Barthélemy, Nicolas R., Vogel, Jacob W., Binette, Alexa Pichet, Chen, Charles D., Aschenbrenner, Andrew J, Gordon, Brian A., Benzinger, Tammie L.S., Holtzman, David M., Morris, John C., Palmqvist, Sebastian, Stomrud, Erik, Janelidze, Shorena, Ossenkoppele, Rik, Schindler, Suzanne E., Bateman, Randall J., Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370223/
https://www.ncbi.nlm.nih.gov/pubmed/37503281
http://dx.doi.org/10.1101/2023.07.14.23292650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370223/
https://www.ncbi.nlm.nih.gov/pubmed/37503281
http://dx.doi.org/10.1101/2023.07.14.23292650

Ejemplares similares